Commission Actions

At the request of the Federal Trade Commission, a federal court has temporarily halted the operation of a sprawling business opportunity scheme that has taken in millions of dollars from consumers...

In a new report, Federal Trade Commission staff detailed key takeaways from an October 2023 public virtual roundtable that examined how generative artificial intelligence, tools that can generate...

The FTC and the State of California moved to dismiss their case challenging John Muir Health’s proposed deal to acquire sole ownership of San Ramon Regional Medical Center, LLC from current majority...

Illumina, Inc. announced it would divest Grail, Inc. following a U.S. Court of Appeals for the Fifth Circuit decision that supported the Federal Trade Commission’s determination that the acquisition...

Today, the Federal Trade Commission and the Justice Department jointly issued the 2023 Merger Guidelines, which describe factors and frameworks the agencies utilize when reviewing mergers and...

The Federal Trade Commission today finalized a consent order that resolves potential competitive harm stemming from Amgen Inc.’s acquisition of Horizon Therapeutics plc. As part of a nationwide...

Following Sanofi’s decision to terminate its proposed acquisition of an exclusive license to Maze Therapeutics Inc.’s developmental drug to treat Pompe disease, the Federal Trade Commission moved to...